|
Re: Apabetalone’s Positive Impact on Pulmonary Arterial Hypertension Published in the American Journal of Respiratory and Critical Care Medicine
|
13
|
Resverlogix Corp.
|
Mar 17, 2022 11:43PM
|
|
Re: So I was able to finally set up a one on one meeting with...
|
6
|
Resverlogix Corp.
|
Mar 15, 2022 04:03PM
|
|
Re: Deja Vu All Over Again
|
9
|
Resverlogix Corp.
|
Mar 11, 2022 08:47PM
|
|
Re: Deja Vu All Over Again
|
7
|
Resverlogix Corp.
|
Mar 11, 2022 05:35PM
|
|
Re: Deja Vu All Over Again
|
10
|
Resverlogix Corp.
|
Mar 11, 2022 03:19PM
|
|
Re: New RVX Video - from Fontier Merchant Capital Group
|
7
|
Resverlogix Corp.
|
Feb 26, 2022 04:13PM
|
|
Re: https://themarkether...
|
1
|
Resverlogix Corp.
|
Feb 22, 2022 04:20PM
|
|
Re: Calgary-developed COVID-19 drug begins trials in local hospitals and Brazil.
|
4
|
Resverlogix Corp.
|
Feb 20, 2022 05:51PM
|
|
Re: Shenzhen Hepalink-Warrants Expiration
|
3
|
Resverlogix Corp.
|
Feb 05, 2022 03:40PM
|
|
Re: Shenzhen Hepalink-Warrants Expiration
|
5
|
Resverlogix Corp.
|
Feb 05, 2022 01:49PM
|
|
Re: CBC Radio News Interview with Dr. Sweeney
|
3
|
Resverlogix Corp.
|
Feb 01, 2022 01:55PM
|
|
Re: CityNews cover
|
6
|
Resverlogix Corp.
|
Jan 31, 2022 01:32PM
|
|
Re: New video quietly released
|
5
|
Resverlogix Corp.
|
Jan 31, 2022 01:15PM
|
|
Re: New video quietly released
|
7
|
Resverlogix Corp.
|
Jan 30, 2022 03:40PM
|
|
Re: New video quietly released
|
11
|
Resverlogix Corp.
|
Jan 29, 2022 08:36PM
|
|
Re: Listen to Dr. Michael Sweeney.
|
6
|
Resverlogix Corp.
|
Jan 25, 2022 01:23PM
|
|
Re: Don on CTV Calgary News 6:18pm
|
8
|
Resverlogix Corp.
|
Jan 25, 2022 01:26AM
|
|
Re: Expected Results
|
4
|
Resverlogix Corp.
|
Jan 22, 2022 12:27PM
|
|
Re: I'm glad dosing has begun... How long until results...
|
3
|
Resverlogix Corp.
|
Jan 20, 2022 08:32PM
|
|
Re: Don On 630 CHED's Afternoon Show
|
6
|
Resverlogix Corp.
|
Jan 20, 2022 03:53PM
|
